Lumentum Holdings Inc. — Form 10-Q Summary
Period clarification: The request identifies “2016 Q3,” but the supplied filing is for the quarter ended April 1, 2017, Lumentum’s fiscal third quarter of 2017. Comparatives are the quarter and nine months ended April 2, 2016. The company notes that the 2016 comparative periods included one additional week.
Business context
Lumentum supplies optical and photonic products for telecommunications, data communications, consumer and industrial applications, and commercial lasers. It reports two segments: Optical Communications (OpComms) and Commercial Lasers (Lasers). The filing is unaudited.
Financial performance
- Quarterly revenue: $255.8 million, up 11.0% from $230.4 million. OpComms revenue was $216.1 million, up 9.6%; Lasers revenue was $39.7 million, up 19.6%.
- Nine-month revenue: $778.9 million, up 17.8% from $661.3 million. OpComms grew 19.8% to $671.0 million; Lasers grew 6.6% to $107.9 million.
- Profitability: Quarterly gross profit was $82.1 million versus $62.8 million, with gross margin improving to 32.1% from 27.3%. Operating income was $13.6 million versus an operating loss of $2.3 million. A $56.0 million net loss compared with a $7.6 million net loss; loss per share was $0.92 versus $0.13.
- Nine-month profitability: Gross profit was $250.8 million versus $197.8 million; gross margin was 32.2% versus 29.9%. Operating income was $43.7 million versus $1.4 million. Net loss was $47.6 million versus $5.0 million; loss per share was $0.80 versus $0.29.
- Drivers and costs: Management attributed revenue growth mainly to OpComms demand, including 100G datacom, super-transport blade and modulator products; Lasers growth reflected fiber-laser demand. OpComms margin rose on higher volume and improved mix. Lasers margin fell to 41.3% from 46.7% for the quarter, principally on higher manufacturing costs.
- Operating expenses: Quarterly R&D was $37.3 million, SG&A $28.1 million, and restructuring charges $3.1 million. Nine-month restructuring charges were $10.0 million versus $3.9 million.
- Unusual earnings item: Derivative remeasurement losses were $56.6 million for the quarter and $74.5 million for nine months, largely reflecting changes in Lumentum’s share price and including the embedded conversion features of preferred stock and the new notes. These losses are non-cash remeasurement items in the reported period; the filing says the embedded derivative losses are nondeductible for tax purposes. The tax provision was $11.6 million for the quarter and $15.4 million for nine months.
Cash flow, balance sheet and debt
- Cash and liquidity: Cash and cash equivalents were $577.9 million at April 1, 2017, compared with $157.1 million at July 2, 2016. Current assets were $941.6 million and current liabilities $192.1 million. Management believes cash and operating cash flows will cover liquidity and capital spending needs for at least 12 months.
- Cash flows, nine months: Operating cash flow was $71.9 million, compared with $73.5 million. Investing cash outflow was $105.1 million, including $100.0 million of capital expenditures and $5.1 million paid for an acquisition. Financing cash inflow was $454.7 million, primarily from the notes issuance.
- Debt: In March 2017, Lumentum issued $450.0 million of 0.25% convertible senior notes due 2024, receiving $443.2 million net of issuance costs. The balance sheet reports a $313.4 million net carrying amount for the debt component and $214.7 million of derivative liabilities. The notes are unsecured; conversions must be settled solely in cash until specified Tax Matters Agreement conditions are met. The company reported estimated note fair value of $482.0 million at quarter-end.
- Investment and commitments: Net property, plant and equipment rose to $246.6 million from $183.4 million; construction in progress included manufacturing equipment expected to enter service within 12 months. Purchase obligations were $110.5 million. The February acquisition carried $3.6 million of contingent/retained consideration, subject to production targets and indemnification terms.
Material changes, outlook and risks
- Revenue and gross margin improved, particularly in OpComms, while reported net losses widened materially because of derivative remeasurement and related tax effects. Nine-month comparisons also reflect an extra week in the prior-year period.
- The company estimates $13.7 million in annualized savings from restructuring actions to date. Management expects to continue investing in R&D and said R&D expense may increase in absolute dollars in future quarters. The filing does not provide specific revenue or earnings guidance.
- Key risks include intense competition and price pressure; customer concentration and limited purchase commitments; dependence on a limited supplier and contract-manufacturer base; manufacturing capacity, yield and facility-transition challenges; and fluctuations in demand, product mix and margins.
- Other important exposures include international operations and foreign exchange, tax uncertainty and potential tax consequences under the Separation agreements, conversion and cash-settlement obligations under the notes, and possible dilution if share settlement becomes available. The company also cites ordinary-course legal claims and environmental, product warranty and regulatory risks.
- Management reported effective disclosure controls and no material changes in internal control over financial reporting during the quarter. It stated that it had no material off-balance-sheet arrangements.
Important facts for investors to verify
- Confirm the period: the supplied filing is fiscal Q3 2017, not 2016 Q3; assess the effect of the extra week in the prior-year comparison.
- Track OpComms and Lasers demand, segment margins, product mix, and whether manufacturing-cost pressure in Lasers persists.
- Monitor the share-price-sensitive derivative liabilities and their non-cash impact on earnings, as well as the associated tax provision.
- Review the notes’ cash-settlement requirement, Tax Matters Agreement conditions, potential conversion or repurchase obligations, and cash available after capital expenditures.
- Assess execution of manufacturing expansion and restructuring, supplier concentration, customer commitments, and the acquisition’s production-target and indemnification contingencies.